2016-07-18,CorMedix Inc. Presentation Now Available For On-Demand Viewing
2016-07-11,CorMedix Inc. To Webcast, Live, At VirtualInvestorConferences.com July 14
2016-04-12,CorMedix Inc. To Present Post-Market Clinical Utility Data From Neutrolin® Usage Monitoring Program On May 23, 2016
2016-01-21,CorMedix To Present At National Kidney Foundation® 2016 Spring Clinical Meetings
2016-01-06,CorMedix To Present At Biotech Showcase™ 2016
2015-12-14,CorMedix Announces Enrollment And Dosing Of First Patient In Phase 3 Neutrolin® Trial In Hemodialysis
2015-10-07,Pacific Premier Bancorp, Inc. Announces The Appointment Of New Director
2015-09-17,4 Stocks Under $10 to Trade for Big Breakouts
2015-09-02,Law Offices Of Howard G. Smith Reminds Investors: Two Days Left To File Lead Plaintiff Motion In The Class Action Lawsuit Against CorMedix, Inc.
2015-09-01,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015
2015-08-31,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. And Encourages Investors To Contact The Firm
2015-08-31,GPM Reminds Investors Of The September 4, 2015 Deadline In The Class Action Lawsuit On Behalf Of CorMedix, Inc. Investors
2015-08-20,GPM Announces The Filing Of A Securities Class Action On Behalf Of CorMedix, Inc. Investors
2015-08-17,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015
2015-08-13,SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In CorMedix, Inc. To Contact The Firm
2015-07-31,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015 - CRMD
2015-07-30,3 Stocks Under $10 Making Big Moves
2015-07-28,CorMedix Stock Sees Short Interest Expand By 40%
2015-07-24,Ryan & Maniskas, LLP Announces Class Action Lawsuit Against CorMedix, Inc.
2015-07-21,Interesting CRMD Put And Call Options For March 2016
2015-07-17,TRADING ALERT: The Rosen Law Firm Reminds CorMedix, Inc. Investors Of The Important Deadline In The Class Action
2015-07-13,Robbins Arroyo LLP: CorMedix, Inc. (CRMD) Misled Shareholders According To A Recently Filed Class Action
2015-07-08,SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against CorMedix Inc.
2015-07-07,EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. To Recover Investor Losses
2015-06-30,CRMD INVESTOR ALERT: Investigation Of CorMedix, Inc., Announced By Glancy Prongay & Murray LLP
2015-06-30,Cormedix (CRMD): Today's Weak On High Volume Stock
2015-06-30,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of CorMedix, Inc.
2015-06-29,EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against CorMedix, Inc. - CRMD
2015-06-22,CorMedix Inc. To Join Russell Global And Russell 3000 Indexes
2015-06-19,Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!
2015-06-17,CorMedix (CRMD) Stock Gains After Receiving Positive FDA Feedback for Neutrolin
2015-06-17,CorMedix Inc. Receives Positive Feedback From FDA For Neutrolin® Clinical Trial Protocol For Oncology Patients
2015-06-12,Cormedix (CRMD): Today's Weak On High Volume Stock
2015-06-11,Oversold Conditions For CorMedix (CRMD)
2015-06-05,Trade-Ideas: Cormedix (CRMD) Is Today's Weak On High Relative Volume Stock
2015-06-01,CorMedix Presents Neutrolin® Post Marketing Surveillance Data At European Renal Association - European Dialysis And Transplant Association (ERA-EDTA) Conference
2015-05-26,Strong On High Relative Volume: Cormedix (CRMD)
2015-05-21,January 2017 Options Now Available For CorMedix (CRMD)
2015-05-18,Trade-Ideas: Cormedix (CRMD) Is Today's Weak On High Relative Volume Stock
2015-05-12,Ratings Changes Today
2015-05-05,CorMedix, Inc. To Report First Quarter Financial Results On May 8, 2015
2015-04-23,CorMedix Presents Data From Neutrolin® Post Marketing Surveillance Study At Two Medical Conferences
2015-04-16,4 Stocks Under $10 Making Big Moves
2015-04-09,CorMedix Institutes Program To Reduce Neutrolin® Cost Of Goods; Reports On Strategic Review Process Managed By Evercore
2015-04-01,The Top-Performing Biotech Stock During a Sizzling First Quarter
2015-03-25,Interesting CRMD Call Options For May 15th
2015-03-20,CorMedix Announces Effectiveness Of Registration Statements For Shares Underlying Publicly Traded Warrants
2015-03-09,CorMedix Clarifies Extension Of Expiration Date For Publicly Traded Warrants
2015-03-04,CorMedix Inc. Provides Multiple Strategic Business Updates
2015-01-29,FDA Grants QIDP Designation To Neutrolin®, CorMedix Inc.'s Lead Product Candidate In The U.S.
2015-01-28,3 Stocks Raising The Drugs Industry Higher
2015-01-15,CorMedix Inc. Receives Fast Track Designation For Neutrolin®
2014-12-23,CorMedix Inc. Finalizes First Middle East Neutrolin® Sales/Distribution Agreement In The Kingdom Of Saudi Arabia
2014-12-04,CorMedix Inc. Files Request With FDA For QIDP Designation For Neutrolin®
2014-12-03,Neutrolin Label Expansion Approved In Germany
2014-11-06,CorMedix, Inc. To Announce Third Quarter 2014 Results On November 13, 2014; Conference Call Hosted At 9 Am On Friday, November 14, 2014
2014-09-25,CorMedix Announces FDA IND Filing For Neutrolin® In United States
2014-09-22,Neutrolin Label Expansion Approved For The European Union
2014-09-16,CorMedix Amends And Restates Outstanding Securities To Remove Provisions Causing Derivative Liability Classification
2014-08-14,FDA Accepts CorMedix, Inc. Pivotal Phase 3 Study Protocol
2014-08-01,4 Biotech Stocks Under $10 to Trade for Breakouts
2014-07-24,CorMedix, Inc. Granted Extension Of NYSE-MKT Listing
2014-06-23,CorMedix, Inc. Finalizes Pivotal Phase 3 Study Protocol For FDA
2014-05-23,CorMedix Notified Of NYSE MKT Listing Deficiency
2014-05-13,CorMedix Inc. To Announce First Quarter 2014 Results On May 15, 2014
2014-04-07,CorMedix Inc. Welcomes Additional Board Members
2014-03-27,CorMedix Inc. To Report 2013 Year End Results On March 31, 2014, And Host Conference Call At 9 Am On April 1, 2014
2014-03-26,3 Biotech Stocks Under $10 to Trade
2014-03-10,CorMedix Inc. Announces Close Of Registered Direct Offering
2014-03-04,CorMedix Inc. Announces Registered Direct Offering
2014-01-21,It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013
2014-01-13,CorMedix Expands NeutrolinA® Sales With Middle East Distribution Agreements
2014-01-10,CorMedix Awarded European Patent For Neutrolin
2014-01-08,CorMedix Inc. To Raise $2,000,000 In Follow On Offering
2013-12-23,CorMedix Receives Minutes From Neutrolin Pre-IND Meeting With FDA
2013-12-12,CorMedix Announces First Sales Of NeutrolinA® In The European Union
2013-11-15,CorMedix To Report Third Quarter Financial Results On November 19, 2013
2013-10-23,CorMedix Inc. Closes $3,000,000 Preferred Stock Offerings
2013-10-18,CorMedix Inc. To Raise $3,000,000 In Concurrent Offerings
2013-09-05,CorMedix Reports Receipt Of European Patent Office Decision To Allow Prosl Patent To Proceed In European Union
2013-07-15,CorMedix Granted Extension Of NYSE MKT Listing
2013-07-05,CorMedix Receives CE Mark For Neutrolin&#174; Catheter Lock Solution
2013-03-27,CorMedix Reports Year End 2012 Financial Results
2013-02-07,CorMedix Granted Extension Of NYSE MKT Listing
2013-01-15,CorMedix Signs Sales And Marketing Agreement With MKM Co-Pharma, Bolsters Commercial Management Team To Ready Neutrolin&#174; Catheter Lock Solution For European Market
2012-11-14,CorMedix: Final Closing Of 2012 Financing
2012-10-11,CorMedix Successfully Completes And Passes ISO 13485 Certification Audit
2012-09-25,CorMedix: Initial Close On Financing And Extension Granted To Regain Compliance With NYSE Amex Listing Standards
2012-07-02,CorMedix: Granted Extension Of NYSE Amex Listing
2012-06-14,CorMedix Provides An Update On CE Marking Process For Neutrolin&#174; In The EU
2012-04-24,CorMedix Receives NYSE Amex Notice Of Delisting For Non-Compliance
2012-03-19,CorMedix Reports Year End 2011 Financial Results
2011-12-30,CorMedix Provides Year End 2011 Update
2011-11-28,CorMedix Appoints Pharmaceutical Veteran, Matthew Duffy To Board Of Directors
2011-11-10,CorMedix Reports Third Quarter 2011 Results
2011-10-07,CorMedix To Host Conference Call On Recent Developments
2011-09-30,CorMedix Announces Strategic Changes
2011-09-29,CorMedix Announces FDA Designation For Neutrolin (CRMD003)
2011-09-07,CorMedix To Present At The Rodman &amp; Renshaw Annual Global Investment Conference
2011-09-06,CorMedix Announces Amended Agreement For CRMD001 (A Proprietary Formulation Of Deferiprone)
2011-08-12,CorMedix Announces Appointment Of Steven W. Lefkowitz To Board Of Directors
2011-08-09,CorMedix Reports Second Quarter 2011 Results
2011-07-07,CorMedix Submits Design Dossier For Neutrolin&#174; (CRMD003) To Start European Approval Process
2011-06-23,CorMedix Provides Regulatory Update For CRMD003 (Neutrolin&#174;)
2011-06-21,CorMedix Announces SPA Agreement With FDA For Phase 3 Trial In The Prevention Of Contrast-Induced Acute Kidney Injury Study With CRMD001 (A Proprietary Formulation Of Deferiprone)
2011-06-14,CorMedix Announces Successful Completion Of Patient Recruitment In Phase II Contrast-Induced Acute Kidney Injury Study With CRMD001 (A Proprietary Formulation Of Deferiprone)
2011-05-10,CorMedix Reports First Quarter 2011 Financial Results
2011-03-31,CorMedix Announces Interim Analysis &amp; Clinical Update For Phase II Study Of CRMD001 (A Proprietary Formulation Of Deferiprone)
2011-03-11,CorMedix Reports Year End 2010 Financial Results
2011-03-02,CorMedix Appoints Mark A. Klausner, M.D. As Chief Medical Officer
2011-02-08,CorMedix To Present At 13th Annual BIO CEO And Investor Conference
2011-01-12,CorMedix Statement On Today&#8217;s Market Activity
2011-01-04,CorMedix Provides Year End Summary Of 2010 Achievements
2010-11-15,CorMedix To Present At The Maxim Group Growth Conference
2010-11-09,CorMedix Reports Third Quarter 2010 Results And Provides Business Update
2010-11-03,CorMedix Awarded Grants From Federal Qualifying Therapeutic Discovery Project Program
2010-10-26,LifeSci Advisors Announces Investment Opinion On CorMedix Inc.
2010-09-28,CorMedix To Present At BIO Investor Forum Conference
2010-09-03,CorMedix To Present At The Rodman &amp; Renshaw Annual Global Investment Conference
2010-08-12,CorMedix Reports Second Quarter 2010 Results
2010-08-10,CorMedix Announces Appointment Of Key Positions
2010-08-03,CorMedix Statement On Today&#8217;s Market Activity
2010-06-29,CorMedix Added To Russell Microcap&#174; Index
2010-06-25,CorMedix Doses First Patient In Phase II Clinical Trial Of CRMD-001
,
